Although there is increasing evidence that E2F1 is associated with ESCCaggressiveness and poor clinical outcomes, the underlying mechanisms ofE2F1-mediated transcriptional regulation in ESCC are not well defined. The gene discussed is E2F1; the disease is esophageal squamous cell carcinoma.